Simulations Plus Market Cap

Simulations Plus has a market cap or net worth of $341.08 million as of July 11, 2025. Its market cap has decreased by -64.23% in one year.

Market Cap

341.08M

Enterprise Value

320.49M

1-Year Change

-64.23%

Ranking

#3279

Market Cap Chart

Since December 1, 1998, Simulations Plus's market cap has increased from $4.50M to $341.08M, an increase of 7,479.63%. That is a compound annual growth rate of 17.65%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	341.10M	-39.06%
Dec 31, 2024	559.70M	-37.27%
Dec 29, 2023	892.20M	20.19%
Dec 30, 2022	742.30M	-22.11%
Dec 31, 2021	953.00M	-33.52%
Dec 31, 2020	1.43B	179.82%
Dec 31, 2019	512.30M	47.76%
Dec 31, 2018	346.70M	24.58%
Dec 29, 2017	278.30M	67.45%
Dec 30, 2016	166.20M	-1.31%
Dec 31, 2015	168.40M	49.69%
Dec 31, 2014	112.50M	38.89%
Dec 31, 2013	81.00M	15.88%
Dec 31, 2012	69.90M	50.00%
Dec 30, 2011	46.60M	11.75%
Dec 31, 2010	41.70M	93.95%
Dec 31, 2009	21.50M	42.38%
Dec 31, 2008	15.10M	-75.25%
Dec 31, 2007	61.00M	42.86%
Dec 29, 2006	42.70M	125.93%
Dec 30, 2005	18.90M	-5.03%
Dec 31, 2004	19.90M	28.39%
Dec 31, 2003	15.50M	89.02%
Dec 31, 2002	8.20M	182.76%
Dec 31, 2001	2.90M	-57.35%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	709.79B
Johnson & Johnson	379.41B
AbbVie	344.45B
Novo Nordisk	316.64B
UnitedHealth Group	271.70B
Novartis AG	243.81B
Abbott Laboratories	232.44B
AstraZeneca	223.49B

Market Cap Rankings